ArticlePharmaceutical research2018

Targeting Suppressive Oligonucleotide to Lymph Nodes Inhibits Toll-like Receptor-9-Mediated Activation of Adaptive Immunity.

Chunsong Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.